Evidence map›Paper›PMID 42093019›Full record

ArticleJournal of medical case reports2026

Jagged-1 mutation is associated with congenital heart defects: a case report.

Othman Alahmed, Manal Alaamery, Fahad Alhabshan, Farah Chaikhouni, Mohamed S Kabbani, Patrice Bouvagnet, Salam Massadeh

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Othman AlahmedMedical Genomics Research Department, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Manal AlaameryMedical Genomics Research Department, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Fahad AlhabshanDepartment of Cardiac Sciences, King Abdullah International Medical Research Center, Ministry of the National Guard, Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, 11481, Riyadh, Saudi Arabia.
Farah ChaikhouniDepartment of Cardiac Sciences, King Abdullah International Medical Research Center, Ministry of the National Guard, Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, 11481, Riyadh, Saudi Arabia.
Mohamed S KabbaniDepartment of Cardiac Sciences, King Abdullah International Medical Research Center, Ministry of the National Guard, Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, 11481, Riyadh, Saudi Arabia.
Patrice BouvagnetLaboratoire Biomnis Eurofins, 17-19 Avenue Tony Garnier, 69007, Lyon, France.
Salam MassadehMedical Genomics Research Department, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia. Massadehsa@mngha.med.sa.ORCID http://orcid.org/0000-0001-9193-0008

Funding

King Abdullah International Medical Research Center RC 15/140
6 · The paper itself

Abstract

backgroundCongenital heart defects (CHD) refer to a wide range of heart structural abnormalities that exist at birth, ranging from malformations with a good prognosis to more complicated and severe lesions. Congenital heart defects can result from mutations in genes encoding cell signaling transducers such as Jagged-1 (JAG1). Mutations in JAG1 are linked to rare autosomal-dominant disorders, often resulting from haploinsufficiency in the Notch signaling pathway, which affects organ development. Reporting novel mutations and associated phenotypes emphasizes the importance of tailored approaches based on individual phenotypic and genotypic profiles. Next-generation sequencing techniques facilitate the detection of disease-associated mutations, enabling the development of personalized management strategies. CASE PRESENTATION: Here, we present a case of a Saudi Arabian female child who was born extremely preterm. She required intubation and mechanical ventilation immediately after birth. She developed bronchopulmonary dysplasia and pulmonary hypertension. At 8 months old, her echocardiogram revealed a large atrial septal defect and a patent ductus arteriosus. She underwent successful patent ductus arteriosus closure. She exhibited severe failure to thrive and was frequently admitted for respiratory infections. Tragically, she passed away at 11 years of age due to pneumonia and pulmonary hypertensive crises. Exome sequencing of the proband, her parents, and her brother identified a previously undescribed likely pathogenic heterozygous missense variant (c.1127A>G) in the JAG1 gene, inherited from her presumed healthy mother, that is associated with an isolated cardiac phenotype.

conclusionAlthough JAG1 mutations typically manifest as Alagille syndrome, this case underscores their phenotypic variability, specifically presenting as an isolated congenital heart defect. The clinical course demonstrates that pulmonary hypertension is a severe complication of an atrial septal defect (ASD), where persistent left-to-right shunting triggers irreversible vascular remodeling and terminal right heart failure. Ultimately, this report confirms the incomplete penetrance characteristic of JAG1 variants and suggests that extreme prematurity may function as a significant epigenetic or environmental modifier.

Indexed as

Ductus Arteriosus, PatentHeart Defects, CongenitalHeart Septal Defects, AtrialJagged-1 ProteinFatal OutcomeFemaleHumansInfantInfant, Extremely PrematureInfant, NewbornMutationJAG1 protein, humanJagged-1 ProteinAtrial septal defectCongenital heart defectsFailure to thriveJAG1Notch signalingPatent ductus arteriosusPulmonary hypertension

Identifiers

PMID42093019
PMCPMC13173698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.